Can You Go Straight to 5mg Mounjaro — and Should You?

Step 1: Why the schedule begins at 2.5mg, not 5mg

Tirzepatide works across two gut-hormone receptors (GIP and GLP-1) simultaneously slowing gastric emptying and reducing appetite signals. That dual action is precisely why it is effective, and precisely why the body needs a settling-in period. The 2.5mg starting dose carries little weight-loss effect on its own; its job is adjustment, giving your digestive system four weeks to stop interpreting the medicine as a novelty worth reacting to violently.

The NHS guidance on tirzepatide is clear that treatment opens at 2.5mg and is increased gradually, the schedule exists because the clinical programme showed that slow titration cuts the rate and severity of gastrointestinal side effects substantially. Patients who tolerate 2.5mg well often find 5mg much smoother as a result. The question of whether you can lose meaningful weight at 2.5mg comes up a lot; the honest answer is that most people don't, which is why reaching 5mg on schedule matters.

One practical note: your 2.5mg pen lives in the fridge at 2–8°C, and keeping a consistent routine around it (same day, same time, same spot in the fridge door) makes it easier to stay on track for that four-week mark. For the exact storage window at room temperature, always check the Patient Information Leaflet.

Step 2: What happens at week four, and what a prescriber checks

After four weeks on 2.5mg, your prescriber reviews how you have got on. This is not a box-ticking exercise. They are looking at real information: whether side effects were manageable, whether any new symptoms appeared, and whether your circumstances have changed. Only once that review is satisfactory does the prescription move to 5mg.

At nume, that review is carried out by a GPhC-registered prescriber, a person reading your update, not software processing a form. If side effects were significant on 2.5mg, your prescriber may recommend staying on the starter dose for a further four weeks before stepping up. That is not a setback; it is the schedule working as intended. Jumping ahead would not accelerate weight loss, the evidence from the SURMOUNT programme shows that therapeutic effect builds across the full titration sequence, not from any single dose in isolation.

If you are curious about what weight loss at 5mg typically looks like once you get there, that question has its own detailed answer.

Step 3: Can the prescriber ever approve 5mg sooner?

In private clinical practice, a prescriber has the flexibility to exercise clinical judgment. However, the SmPC (the official prescribing document) specifies four-week intervals between dose increases, and any deviation would require a documented clinical reason. In practice, starting at 5mg is not something a responsible prescriber would agree to: the tolerability data does not support it, and the starter dose period is short enough that there is nothing meaningful to gain by cutting it.

Transfer patients (people already established on Mounjaro at another service) are a different situation. If you have a verifiable prescription history showing you have tolerated a given dose, a prescriber can assess whether it is appropriate to continue at that dose. You can read more about how Mounjaro works and the full dose range on the main Mounjaro page. The step from 5mg upward follows the same logic; for instance, moving from 5mg to 10mg requires its own prescriber review at the right interval.

Pricing can feel like a factor in these conversations, if a higher dose costs more, some people wonder whether staying lower for longer is financially sensible. For context on how Mounjaro's UK pricing has changed, that page covers the background. Cost is a legitimate concern, but dose decisions belong in the clinical conversation, not the checkout.

What to do if side effects are making 5mg feel daunting

A meaningful number of people who ask about skipping the starter dose are actually asking about something else: they are worried that moving to 5mg will bring worse side effects than 2.5mg. That is a fair concern, and worth raising directly with your prescriber rather than trying to engineer the titration yourself.

Common GI effects (nausea, loose stools, constipation, burping) tend to peak around dose increases and settle within one to two weeks for most people. If 2.5mg caused significant trouble, your prescriber needs to know; they may slow the titration, suggest timing adjustments, or advise on symptom management. Sulphur burps in particular are a frequently reported and well-documented experience at 5mg, manageable, but good to know about in advance.

Our 5mg Mounjaro page covers what most people experience at that dose and what the clinical evidence says about it. If you have specific questions about your own situation, the clearest route is speaking to a prescriber directly. Speak to our prescribers through a free consultation, reviewed the same day, no waiting list.